@Shebakoby said:
I have to wonder where drug companies are making up the difference in order to stay in business. Price controls would certainly put a damper on new drug research in Canada, unless a manufacturer could produce it relatively cheaply to fit under the price control.
They are price-gouging the fuck out of the Americans, that's where. What the drug companies won't tell you is that several of them are heavily-invested in a variety of generic manufacturers. So, the generics aren't really competing against them: they are actually demonstrating how badly American consumers are getting price-gouged.
I do recall one time over a decade ago the governor of Oregon was in town for something, and some reporter asked him about how long health care waiting list times were in Oregon. The man was competely confused. He was like "Waiting list times, what are those even?" He didn't even know such a concept existed.
I didn't know they existed when I lived in Canada for 23 years. I only came upon them when I came to the United States.
The reason is simple: whereas Canadian hospitals have bed shortages, American hospitals usually do not. American hospitals are owned by private companies that are attempting to eat each other's market share. It is in their interests to make sure that their hospitals are not at capacity, and this results in higher costs per patient. In Canada, there's more of an interest in keeping the hospitals at over-capacity for efficiency reasons.